Previous 10 | Next 10 |
PerkinElmer Inc. (NYSE:PKI) traded today at a new 52-week high of $169.11. This new high was reached on approximately average trading volume as 499,000 shares traded hands, while the average 30-day volume is approximately 664,000 shares. PerkinElmer provides instruments, tests, services,...
Atstock Productions/iStock via Getty Images Privately-held BioLegend is a provider of antibodies and reagents in areas such as cytometry, proteogenomics, multiplex assays, recombinant proteins, magnetic cell separation, and bioprocessing. BioLegend has over 700 employees based in the U.S., wi...
PerkinElmer (PKI): Q2 Non-GAAP EPS of $2.83 beats by $0.39; GAAP EPS of $2.19 beats by $0.19.Revenue of $1.23B (+51.5% Y/Y) beats by $110M.For the third quarter of 2021, the Company forecasts adjusted revenue of ~$1.00B vs. consensus of $969.34M and adjusted earnings per share of $1.62 v...
Revenue of $1.228 billion; 51% reported growth; 41% organic growth GAAP EPS from continuing operations of $2.19; Adjusted EPS of $2.83 Initiates Third Quarter and Raises Full-Year Revenue and Earnings Guidance Announces Agreement to Acquire BioLegend –...
Transformative deal significantly scales leading position in life science to accelerate legendary discoveries in precision medicine Leader in antibody development with highly complementary, innovative portfolio in emerging, high-growth areas of biologics, cell and gene t...
Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...
Shares of PerkinElmer Inc. (NYSE:PKI) traded today at $163.99, eclipsing its 52-week high. This new high was reached on below average trading volume as 235,000 shares traded hands, while the average 30-day volume is approximately 653,000 shares. Over the past year, PerkinElmer Inc. has t...
A dashboard with metrics in healthcare industries. Value and quality scores, and their evolution since last month. Focus on IDNA. A list of cheap stocks. For further details see: IDNA And Healthcare Dashboard For July
Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...
Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...
News, Short Squeeze, Breakout and More Instantly...
Revenue of $675 million; (30)% reported growth; (27)% organic growth; 6% non-COVID organic growth GAAP EPS of $4.50; Adjusted EPS from continuing operations of $1.01 Updates full year 2023 guidance Authorizes new $600 million share repurchase program To begin tradi...
Transformation aimed at revolutionizing next generation scientific breakthroughs that solve the world’s greatest health challenges Trusted partner to pharma, government and diagnostics customers with complete, end-to-end solutions To begin trading as RVTY under new name on ...
2023-05-07 19:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...